Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04214119 · ClinicalTrials.gov registry record
EsophaCap for the Detection of Early Esophageal Carcinoma
A clinical trial of Gastric Cancer and Esophageal Cancer, sponsored by Johns Hopkins University.
- Recruiting
- Registry status
- 2,500
- Enrollment target
- 2
- Study locations
NCT04214119 is a study of Gastric Cancer and Esophageal Cancer that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 2,500 participants, above the 303-participant average among 153 other Gastric Cancer trials with a reported enrollment target (725% higher). The trial reports 2 study locations across 1 state.
The verdict
NCT04214119, a study of Gastric Cancer and Esophageal Cancer, is actively recruiting participants, sponsored by Johns Hopkins University.
- RECRUITING
- Registry status
- 2,500 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study is to identify potential biomarkers for the early detection of Barrett's Esophagus, esophageal carcinoma (both adenocarcinoma and squamous cell carcinoma), and gastric cancer via sponge cytology.
Conditions Studied
Study Locations (2)
Maryland
- Bayview Medical Center - Baltimore
- Johns Hopkins Hospital - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,500 participants |
| Start Date | 2016-01-12 |
| Est. Completion | 2028-12-19 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04214119
The ClinicalTrials.gov registry entry for NCT04214119 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 303-participant average among 153 other Gastric Cancer trials with a reported enrollment target (725% higher). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Gastric Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT04214119 reports 2 study locations spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT04214119 about?
NCT04214119 is a clinical study titled "EsophaCap for the Detection of Early Esophageal Carcinoma". This study is to identify potential biomarkers for the early detection of Barrett's Esophagus, esophageal carcinoma (both adenocarcinoma and squamous cell carcinoma), and gastric cancer via sponge cytology.
What is the current status of trial NCT04214119?
This trial is currently recruiting. The enrollment target is 2,500 participants. The study started on 2016-01-12. Estimated completion is 2028-12-19.
What conditions does trial NCT04214119 study?
This clinical trial studies the following conditions: Gastric Cancer, Esophageal Cancer, Barrett Esophagus.
Who is sponsoring clinical trial NCT04214119?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04214119 being conducted?
This trial has 2 study locations across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastric Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
CONFIRM: Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
-
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
RECRUITING · Phase 1
-
KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer
RECRUITING · Phase 1
-
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
RECRUITING · Phase 1
-
A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
RECRUITING · Phase 1
-
[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.